Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > News

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Jun 18, 2024 8:50am

162 Views

Post# 36093612

RE:RE:RE:RE:RE:News

Tookad and Radachlorin were administered IV and were way less tumor specific and also have amazing results. The fact that our drug binds to transferrin and cancer cells are hungry for iron, pretty much guarantees success. But yes we will need to verify in Human trials for GBM and others. Keep in mind that human Tumor cell lines were used in preclinical studies.

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand